Evidence map›Paper›PMID 30949687›Full record

ArticleCardiovascular research2019

A sequential interferon gamma directed chemotactic cellular immune response determines survival and cardiac function post-myocardial infarction.

Stefanie Finger, Maike Knorr, Michael Molitor, Rebecca Schüler, Venkata Garlapati, Ari Waisman, Moritz Brandt, Thomas Münzel, Tobias Bopp, Sabine Kossmann and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Cardiovascular research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Interferon gamma signaling drives cardiac metabolic rewiring.bioRxiv : the preprint server for biology · 2025
    Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Interferons and interferon-related pathways in heart disease.Frontiers in cardiovascular medicine · 2024
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 1 institution in 2 countries.

Stefanie FingerCenter for Cardiology-Cardiology I, University Medical Center Mainz, Langenbeckstraße 1, Mainz, Germany.
Maike KnorrCenter for Cardiology-Cardiology I, University Medical Center Mainz, Langenbeckstraße 1, Mainz, Germany.
Michael MolitorCenter for Cardiology-Cardiology I, University Medical Center Mainz, Langenbeckstraße 1, Mainz, Germany.
Rebecca SchülerCenter for Cardiology-Cardiology I, University Medical Center Mainz, Langenbeckstraße 1, Mainz, Germany.
Venkata GarlapatiCenter for Thrombosis and Hemostasis, University Medical Center Mainz, Langenbeckstraße 1, Mainz, Germany.
Ari WaismanInstitute for Molecular Medicine, University Medical Center Mainz, Langenbeckstraße 1, Mainz, Germany.
Moritz BrandtCenter for Cardiology-Cardiology I, University Medical Center Mainz, Langenbeckstraße 1, Mainz, Germany.
Thomas MünzelCenter for Cardiology-Cardiology I, University Medical Center Mainz, Langenbeckstraße 1, Mainz, Germany.
Tobias BoppInstitute for Immunology, University Medical Center Mainz, Langenbeckstraße, 1, Mainz, Germany.
Sabine KossmannCenter for Cardiology-Cardiology I, University Medical Center Mainz, Langenbeckstraße 1, Mainz, Germany.
Susanne KarbachCenter for Cardiology-Cardiology I, University Medical Center Mainz, Langenbeckstraße 1, Mainz, Germany.
Philip WenzelCenter for Cardiology-Cardiology I, University Medical Center Mainz, Langenbeckstraße 1, Mainz, Germany.
Johannes Gutenberg University Mainz · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsMyelomonocytic cells are critical in injury and healing post-myocardial infarction (MI). Mechanisms of regulation, however, are incompletely understood. The aim of the study was to elucidate the role of interferon gamma (IFN-γ) in the orchestrated inflammatory response in a murine model of MI. METHODS AND

resultsMI was induced in 8- to 12-week-old male mice (C57BL/6 background) by permanent ligation of the left anterior descending (LAD) coronary artery. Lysozyme M (LysM)+ cell-depleted LysMiDTR transgenic mice displayed a reduced influx of CD45.2+/CD3-/CD11b+/Gr-1high neutrophils into infarcted myocardium 1 day post-MI compared with infarcted controls, paralleled by decreased cardiac mRNA levels of IFN-γ and tumour necrosis factor alpha (TNF-α). Mortality after MI was significantly increased in LysM+ cell-depleted mice within 28 days post-MI. To more specifically address the role of neutrophils, we depleted C57BL/6 mice with a monoclonal anti-Gr-1 antibody and found increased mortality, deteriorated cardiac function as well as decreased cardiac IFN-γ mRNA expression early after MI. Ccl2, Cxcl1, Cx3cl1, and Il12b mRNA were reduced 3 days after MI, as was the amount of CD11b+/Ly-6G-/Ly-6Chigh inflammatory monocytes. LAD-ligated Cramp-/- mice lacking cathelicidin important in neutrophil-dependent monocyte chemotaxis as well as IFNγ-/- and TNFα-/- mice phenocopied Gr-1+ cell-depleted mice, supporting a regulatory role of IFN-γ impacting on both the sequence of inflammatory cell invasion and cardiac outcome early after MI. The use of conditional IFN-γ receptor deficient mice indicated a direct effect of IFN-γ on LysM+ cells in cardiac injury post-MI. Using IFN-γ reporter mice and flow cytometry, we identified cardiac lymphoid cells (CD4+ and CD8+ T cells and natural killer cells) as primary source of this cytokine in the cardiac inflammatory response post-MI.

conclusionIFN-γ directs a sequential chemotactic cellular immune response and determines survival and cardiac function post-MI.

Indexed as

Chemotaxis, LeukocyteImmunity, CellularAnimalsAntimicrobial Cationic PeptidesCathelicidinsCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesDisease Models, AnimalInterferon-gammaInterferon gamma ReceptorKiller Cells, NaturalLymphocytesMaleMice, Inbred C57BLMice, KnockoutMuramidaseAntimicrobial Cationic PeptidesCathelicidinsIFNG protein, mouseInterferon-gammaInterferon gamma Receptorlysozyme M, mouseMuramidaseReceptors, InterferonTnf protein, mouseTumor Necrosis Factor-alphaInterferon gammaMyelomonocytic cellsMyocardial infarction

Identifiers

PMID30949687
OpenAlexW2927898770

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.